Return to homepagePandemic Pact

Immune monitoring in COVID-19 patients

Grant number: Unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020

  • Funder

    NWO Netherlands

  • Principal Investigator

    Prof dr CHJ van Eijck

  • Research Location

    Netherlands

  • Lead Research Institution

    Erasmus MC

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Prognostic factors for disease severity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Currently it is not clear which patients who are admitted to the hospital with a SARS-CoV-2 infection will benefit from treatment or die. Clearly, the balanced immune system is lost in some of the SARS-CoV-2 infected patients which contributes to the progression in disease. We believe that monitoring the immunological changes induced by the SARS-CoV-2 virus will lead to discovering prognostic or predictive markers that may assist in decision making and offers therapeutic options.